Nutraceutical contract manufacturing market seen topping $340B by 2030

The Business Research Company says the global nutraceutical contract manufacturing services market will exceed $340 billion by 2030, led by Asia-Pacific and the U.S. The report points to preventive health, supplement demand and regulatory pressure as the main forces pushing brands toward outsourced production.

Why it matters: - The market is projected to hit more than $340 billion by 2030, putting nutraceutical contract manufacturing near the scale of the much larger food contract manufacturing market. - The growth signals continued outsourcing by nutraceutical brands that need scale, compliance support and faster product launches. - The report also frames nutraceutical manufacturing as a meaningful slice of the broader hospitality industry, underscoring how large the category has become.

What happened: - The Business Research Company released its 2026 market report on nutraceutical contract manufacturing services, with a global forecast through 2035. - The market is expected to grow at a 12% CAGR through 2030. - Asia-Pacific is forecast to be the largest region in 2030, with a market value of $113 billion. - The U.S. is projected to be the largest country in 2030, with a market value of $94 billion. - Dietary supplements are expected to remain the biggest product segment, accounting for 69% of the market, or $236 billion, in 2030.

The details: - Asia-Pacific is expected to grow from $63 billion in 2025 to $113 billion in 2030 at a 13% CAGR. - The report links Asia-Pacific growth to rising health awareness, stronger demand for dietary supplements and functional foods, larger middle classes, higher disposable incomes and more outsourcing by nutraceutical brands. - The U.S. market is projected to rise from $55 billion in 2025 to $94 billion in 2030 at an 11% CAGR. - The U.S. growth case centers on high supplement use, demand for clean-label and scientifically validated products, innovation in gummies and powders, and stronger focus on quality and regulatory compliance. - The market is segmented by product into dietary supplements and functional food and beverages. - The market is segmented by dosage form into tablets, capsules, liquid oral, powder in sachet or jar, gummies, energy bars and other forms. - The market is segmented by end user into big pharmaceutical companies, small and medium sized pharmaceutical companies, generic pharmaceutical companies and other end users. - Dietary supplements are supported by demand for vitamins, minerals, probiotics and botanical extracts, plus greater interest in convenient daily supplementation. - The report says dietary supplements and functional food and beverages together represent the biggest growth opportunity, with more than $145 billion in combined value by 2030. - The dietary supplements segment is projected to add $101 billion from 2025 to 2030. - The functional food and beverages segment is projected to add $44 billion over the same period. - The report says new 2026 features include market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technology analysis and updated graphics and tables. - Request a free sample of the report - Access the detailed market report

Between the lines: - The report’s growth drivers point to a broader shift toward preventive healthcare, not just demand for supplements. - Regulatory complexity is also pushing brands to outsource more production to manufacturers with compliance systems and certification expertise. - The emphasis on personalized nutrition, scalable production and faster commercialization suggests competition will center on formulation capability as much as capacity. - The disclaimer makes clear the figures are estimates and opinions from the report, not statements of fact or investment guidance.

What's next: - Brands and manufacturers are likely to keep expanding into convenient formats such as gummies, powders and ready-to-use supplement products. - Contract manufacturing providers with advanced production technology and stronger compliance systems may capture more outsourced work. - Investors and operators will likely watch Asia-Pacific growth and U.S. premium product demand as the clearest demand signals through 2030. - The report positions dietary supplements and functional food and beverages as the main areas to watch for incremental market gains.

The bottom line: - Nutraceutical contract manufacturing is on track for another strong growth cycle, with outsourcing, preventive health demand and regulation driving the market toward the $340 billion mark by 2030.